Novartis AG is 374.9x more valuable than Jade Biosciences, Inc. by market capitalization ($283.13 B vs $755.21 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JBIO | NVS |
|---|---|---|
| Market cap | $755.21 M | $283.13 B |
| US-listed rank | #2665 | #47 |
| Net income (latest FY) | -$127.41M | - |
| SEC filings | 479 | 947 |
Novartis AG is 374.9x more valuable than Jade Biosciences, Inc. by market capitalization ($283.13 B vs $755.21 M).
Full pages: Jade Biosciences, Inc. and Novartis AG, or browse the full rankings.